Dan,
I think Jason mentioned that the Bausch & Lomb products still needed some documents to go through the whole approval process. Well its Summer time and its not time for small cap, but I agreed with you that 0.70 is a bit too low for a steady growing biotech. No junior biotech is not under pressure & each of them sink to the bottom. I can give you examples...AXB, BNC, BLM,BIA, IZP, NRT, NVN.....My whole portfolio of biotech worth only 1/2. If one of the biotech get a blockbuster drug in the market , then the whole picture change, and everybody go after biotech again. It may take 1 month or 1 to 2 years, who know.
The bottom line is to make some money, I think we have to wait until Helix get a better balance sheet(cut the loss to minimum) then we'll see the stock price go way up.This is my opinion.
George
What is your opinion of RRK. I think 0.19 or 0.20 is the time to buy again.I am waiting for John report back from his visit to RRK's office |
